# SILEXION THERAPEUTICS CORP ORD SHS NEW

SILEXION THERAPEUTICS CORP ORD SHS NEW is a security (CUSIP G1281K130) tracked across SEC portfolio filings. 4 institutional managers reported $42K on Form 13F as of 2026-03-31.

## Summary

- Issuer: SILEXION THERAPEUTICS CORP
- Class: ORD SHS NEW
- CUSIP: G1281K130
- 13F holders: 4
- 13F value: $42K
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [CITADEL ADVISORS LLC](https://search.stillhousedata.com/firm/148826) | MIAMI, FL | $27K | 20,926 |
| [TWO SIGMA SECURITIES, LLC](https://search.stillhousedata.com/firm/148960) | New York, NY | $15K | 11,657 |
| UBS Group AG | Zurich, V8 | $662 | 517 |
| JONES FINANCIAL COMPANIES LLLP | DES PERES, MO | $32 | 26 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/G1281K130.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.